{"id":36324,"date":"2025-07-22T15:00:19","date_gmt":"2025-07-22T12:00:19","guid":{"rendered":"https:\/\/massivebio.com\/?p=36324"},"modified":"2025-07-22T15:00:19","modified_gmt":"2025-07-22T12:00:19","slug":"breast-cancer-screening-guidelines-whats-changed-in-2025","status":"publish","type":"post","link":"https:\/\/massivebio.com\/breast-cancer-screening-guidelines-whats-changed-in-2025\/","title":{"rendered":"Breast Cancer Screening Guidelines: What\u2019s Changed in 2025?"},"content":{"rendered":"<section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><h2><span style=\"font-weight: 400;\">Breast Cancer Screening Guidelines: What\u2019s Changed in 2025?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">In 2025, changes to the breast cancer screening guidelines are reshaping how women, and their healthcare providers, approach early detection and prevention. With evolving technologies, updated research, and a growing understanding of genetic risks, new recommendations reflect a more personalized and proactive approach.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">From adjusting the breast cancer screening age to expanding tools like <\/span><b>ultrasound for breast cancer screening<\/b><span style=\"font-weight: 400;\">, these updates aim to detect cancer earlier and improve outcomes for everyone, especially those in high-risk categories. Whether you&#8217;re someone with no family history or you&#8217;re wondering, <\/span><i><span style=\"font-weight: 400;\">&#8220;<\/span><\/i><b>My mom had breast cancer, when should I get a mammogram?<\/b><i><span style=\"font-weight: 400;\">&#8220;<\/span><\/i><span style=\"font-weight: 400;\">, staying informed is critical. This breakdown covers what\u2019s new, what remains unchanged, and how to navigate the latest breast cancer screening recommendations for 2025.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Why Breast Cancer Screening Matters Now More Than Ever?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Breast cancer screening matters more than ever because early detection significantly improves treatment success, and the 2025 guidelines promote personalized screening to better identify and manage risk. In 2025, breast cancer is expected to affect over 300,000 women, maintaining its status as a leading cancer among women. Regular screening enables early detection, which is vital for successful <\/span><a href=\"https:\/\/massivebio.com\/breast-cancer-treatment\/\"><span style=\"font-weight: 400;\">breast cancer treatment.<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">But not all screenings are created equal. Various factors influence how and when someone should be screened, including age, personal risk, and family history. That\u2019s why new <\/span><b>breast cancer screening guidelines<\/b><span style=\"font-weight: 400;\"> for 2025 are moving away from a one-size-fits-all model and toward more individualized protocols.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Thanks to advancements in diagnostics and a deeper understanding of cancer risk, the 2025 guidelines include more flexible screening intervals, updated imaging recommendations, and expanded criteria for identifying high-risk individuals. The goal? To make screening smarter\u2014not just more frequent.\u00a0<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">What\u2019s Different in the 2025 Breast Cancer Screening Recommendations?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">The 2025 guidelines lower screening to age 40, personalize intervals by risk, and add ultrasound and MRI for better detection. In 2025, both ACOG and ACS updated their recommendations with some key changes while maintaining core principles:<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Lower Screening Age for Some Groups<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">One of the most significant updates in 2025 is the lowered <\/span><b>breast cancer screening age<\/b><span style=\"font-weight: 400;\"> for average-risk individuals. Both ACOG and ACS now recommend that:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Women at average risk begin mammograms at age 40 (previously 45 by ACS)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>ACOG breast cancer screening <\/b><span style=\"font-weight: 400;\">continues annually or biennially through age 74, depending on patient preference and physician guidance<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">This change was driven by recent studies indicating an increase in <\/span><b>early stage breast cancer mammogram<\/b><span style=\"font-weight: 400;\"> findings in women aged 40\u201344. Detecting cancer early can greatly decrease the need for aggressive treatments and boost survival chances.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Personalized Screening Intervals<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">The 2025 guidelines encourage personalized screening intervals. Rather than recommending one strict timeline for everyone, clinicians now assess risk factors such as:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Family history of breast or ovarian cancer<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Genetic mutations (e.g., BRCA1, BRCA2)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Breast density<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Personal medical history<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">For example, someone with a family history may begin <\/span><b>breast cancer mammogram<\/b><span style=\"font-weight: 400;\"> screening earlier and more frequently. This personalized approach ensures high-risk individuals don\u2019t fall through the cracks while minimizing unnecessary testing for lower-risk patients.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Ultrasound and MRI Integration<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Another key update involves the increased use of <\/span><b>breast cancer screening<\/b><span style=\"font-weight: 400;\"> and breast MRIs. These tools are now part of routine screening for:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Women with dense breast tissue, where mammograms may miss small tumors<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Individuals with genetic predisposition or strong family history<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Patients under 40 with concerning symptoms<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">While mammograms remain the gold standard, combining them with other <\/span><b>breast cancer screening tests<\/b><span style=\"font-weight: 400;\"> improves accuracy, especially in those at higher risk.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">What Should High-Risk Individuals Know About Breast Cancer Screening?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">High-risk individuals with a family history of breast cancer should know that they should generally start screening 10 years before their relatives are diagnosed and can benefit from annual MRIs and genetic counseling as part of their care.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">If you\u2019re asking, <\/span><i><span style=\"font-weight: 400;\">&#8220;My mom had breast cancer\u2014when should I get a mammogram?&#8221;<\/span><\/i><span style=\"font-weight: 400;\">, you\u2019re not alone. Family history is a significant predictor of risk, and 2025&#8217;s <\/span><a href=\"https:\/\/massivebio.com\/screening-for-breast-cancer-icd-10\/\"><span style=\"font-weight: 400;\">screening for breast cancer<\/span><\/a><span style=\"font-weight: 400;\"> ICD 10 guidelines for family history make this clear.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Screening for High-Risk Individuals<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">The updated <\/span><b>high risk breast cancer screening guidelines <\/b><span style=\"font-weight: 400;\">now include:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Starting mammograms as early as age 30<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Annual MRIs in addition to mammograms<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Genetic counseling and testing for those with a first-degree relative who had breast cancer<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">If a close family member was diagnosed before age 50, experts suggest beginning screening 10 years earlier than their age at diagnosis. A family history like a mother\u2019s diagnosis at 45 means screening should start at 35.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Genetic Mutations and Preventive Strategies<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Those with BRCA mutations or other genetic markers are also eligible for more intensive monitoring. Beyond imaging, some may consider risk-reducing medications or even preventive surgeries, based on guidance from their care team.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">This personalized, risk-based screening approach focuses resources on those who need them most, while avoiding unnecessary tests for low-risk patients.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">What Should You Know About Screening Tests Beyond Mammograms?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">You should know that breast cancer detection can also include ultrasound, MRI, and clinical breast exams. These tests are used based on individual risk factors like breast density and family history to improve detection while reducing unnecessary testing.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cWhen people hear \u2018breast cancer screening,\u2019 they typically think of mammograms\u2014and for good reason. Breast cancer mammogram technology continues to improve, and 3D mammography (tomosynthesis) is now widely recommended according to <\/span><b>breast cancer screening guidelines family history<\/b><span style=\"font-weight: 400;\"> considerations.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400;\">But in 2025, there are now multiple breast cancer screening tests used depending on the individual:<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Mammography<\/span><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Best for: All women starting at age 40<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Frequency: Every 1\u20132 years, depending on risk<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Detects: Tumors before they can be felt<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">Breast Ultrasound<\/span><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Best for: Women with dense breasts or symptoms under 40<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Frequency: As needed based on doctor evaluation<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Strength: Useful in differentiating solid tumors from cysts<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">Breast MRI<\/span><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Best for: High-risk individuals<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Frequency: Annual, often paired with mammogram<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Strength: Very sensitive, but can lead to false positives<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">Clinical Breast Exam<\/span><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Best for: Supplement to imaging for all age groups<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Frequency: Every 1\u20133 years under 40, annually after<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Note: Not a substitute for imaging<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">The 2025 guidelines place greater emphasis on using the right test at the right time, helping to avoid both over-testing and under-diagnosis.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">How Can You Take Action with the 2025 Breast Cancer Screening Guidelines?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Take action by knowing your risk, starting screenings on time, asking about extra tests if needed, and staying informed. Whether you\u2019ve already had multiple screenings or are considering your first mammogram, knowing the current guidelines helps you advocate for your health. Here\u2019s how you can apply the 2025 updates to your personal situation:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Know Your Risk: <\/span><span style=\"font-weight: 400;\">Talk to your doctor about your personal and family medical history. Ask whether you fall into a high-risk category and if genetic counseling is appropriate.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Start Screening on Time: <\/span><span style=\"font-weight: 400;\">According to <\/span><b>ACS breast cancer screening<\/b><span style=\"font-weight: 400;\">, if you&#8217;re 40 or older, you should begin regular screening. If you&#8217;re under 40 with risk factors, ask your doctor whether you should start earlier.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Ask About Additional Testing: <\/span><span style=\"font-weight: 400;\">If you have dense breasts, don\u2019t hesitate to ask about adding ultrasound or MRI to your routine. These tools can improve detection dramatically.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Make It Routine: <\/span><span style=\"font-weight: 400;\">Set reminders for annual screenings and check-ups. Early detection only works if it&#8217;s consistent.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Stay Informed: <\/span><span style=\"font-weight: 400;\">Breast cancer research is advancing quickly. Keep up with <\/span><b>new breast cancer screening<\/b><span style=\"font-weight: 400;\"> technologies and guideline updates through trusted sources like ACOG and ACS.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">The breast cancer screening guidelines in 2025 reflect a major shift toward personalized, proactive care. With a lower starting age for mammograms, increased use of advanced imaging like ultrasound and MRI, and better risk assessment tools, women now have more resources than ever to catch cancer early.<\/span><a href=\"https:\/\/massivebio.com\/breast-cancer-clinical-trials\/\"><span style=\"font-weight: 400;\"> Pushing boundaries in breast cancer clinical trials<\/span><\/a><span style=\"font-weight: 400;\"> has also led to innovations that complement these screening advances, offering new hope through targeted therapies and earlier intervention.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Whether you&#8217;re scheduling your first breast cancer mammogram, navigating family risk factors, or supporting a loved one through screening decisions, knowledge is your best defense.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">By understanding these new <\/span><b>breast cancer screening recommendations<\/b><span style=\"font-weight: 400;\">, you\u2019re taking a powerful step toward protecting your long-term health\u2014and possibly saving a life. Experience how Massive Bio brings hope by delivering innovative, personalized, and accessible cancer care at every step.<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"Breast Cancer Screening Guidelines: What\u2019s Changed in 2025? In 2025, changes to the breast cancer screening guidelines are reshaping how women, and their healthcare providers, approach early detection and prevention. With evolving technologies, updated research, and a growing understanding of genetic risks, new recommendations reflect a more personalized and proactive approach. From adjusting the breast...","protected":false},"author":11,"featured_media":36325,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[57],"tags":[],"class_list":["post-36324","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Breast Cancer Screening Guidelines: What\u2019s Changed in 2025?<\/title>\n<meta name=\"description\" content=\"In 2025, changes to the breast cancer screening guidelines are reshaping how women, and their healthcare providers, approach early detection and prevention.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/massivebio.com\/breast-cancer-screening-guidelines-whats-changed-in-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Breast Cancer Screening Guidelines: What\u2019s Changed in 2025? %\" \/>\n<meta property=\"og:description\" content=\"In 2025, changes to the breast cancer screening guidelines are reshaping how women, and their healthcare providers, approach early detection and prevention.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/massivebio.com\/breast-cancer-screening-guidelines-whats-changed-in-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Massive Bio\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-22T12:00:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/07\/Breast-Cancer-Screening-Guidelines_-Whats-Changed-in-2025-4.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"767\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Sinan Gul\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:site\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sinan Gul\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Breast Cancer Screening Guidelines: What\u2019s Changed in 2025?","description":"In 2025, changes to the breast cancer screening guidelines are reshaping how women, and their healthcare providers, approach early detection and prevention.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/massivebio.com\/breast-cancer-screening-guidelines-whats-changed-in-2025\/","og_locale":"en_US","og_type":"article","og_title":"Breast Cancer Screening Guidelines: What\u2019s Changed in 2025? %","og_description":"In 2025, changes to the breast cancer screening guidelines are reshaping how women, and their healthcare providers, approach early detection and prevention.","og_url":"https:\/\/massivebio.com\/breast-cancer-screening-guidelines-whats-changed-in-2025\/","og_site_name":"Massive Bio","article_publisher":"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","article_published_time":"2025-07-22T12:00:19+00:00","og_image":[{"width":1024,"height":767,"url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/07\/Breast-Cancer-Screening-Guidelines_-Whats-Changed-in-2025-4.webp","type":"image\/webp"}],"author":"Sinan Gul","twitter_card":"summary_large_image","twitter_creator":"@MassiveBio","twitter_site":"@MassiveBio","twitter_misc":{"Written by":"Sinan Gul","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/massivebio.com\/breast-cancer-screening-guidelines-whats-changed-in-2025\/#article","isPartOf":{"@id":"https:\/\/massivebio.com\/breast-cancer-screening-guidelines-whats-changed-in-2025\/"},"author":{"name":"Sinan Gul","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6"},"headline":"Breast Cancer Screening Guidelines: What\u2019s Changed in 2025?","datePublished":"2025-07-22T12:00:19+00:00","mainEntityOfPage":{"@id":"https:\/\/massivebio.com\/breast-cancer-screening-guidelines-whats-changed-in-2025\/"},"wordCount":1362,"commentCount":0,"publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"image":{"@id":"https:\/\/massivebio.com\/breast-cancer-screening-guidelines-whats-changed-in-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/07\/Breast-Cancer-Screening-Guidelines_-Whats-Changed-in-2025-4.webp","articleSection":["Blog"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/massivebio.com\/breast-cancer-screening-guidelines-whats-changed-in-2025\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/massivebio.com\/breast-cancer-screening-guidelines-whats-changed-in-2025\/","url":"https:\/\/massivebio.com\/breast-cancer-screening-guidelines-whats-changed-in-2025\/","name":"Breast Cancer Screening Guidelines: What\u2019s Changed in 2025?","isPartOf":{"@id":"https:\/\/massivebio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/massivebio.com\/breast-cancer-screening-guidelines-whats-changed-in-2025\/#primaryimage"},"image":{"@id":"https:\/\/massivebio.com\/breast-cancer-screening-guidelines-whats-changed-in-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/07\/Breast-Cancer-Screening-Guidelines_-Whats-Changed-in-2025-4.webp","datePublished":"2025-07-22T12:00:19+00:00","description":"In 2025, changes to the breast cancer screening guidelines are reshaping how women, and their healthcare providers, approach early detection and prevention.","breadcrumb":{"@id":"https:\/\/massivebio.com\/breast-cancer-screening-guidelines-whats-changed-in-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/massivebio.com\/breast-cancer-screening-guidelines-whats-changed-in-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/breast-cancer-screening-guidelines-whats-changed-in-2025\/#primaryimage","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/07\/Breast-Cancer-Screening-Guidelines_-Whats-Changed-in-2025-4.webp","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/07\/Breast-Cancer-Screening-Guidelines_-Whats-Changed-in-2025-4.webp","width":1024,"height":767,"caption":"Breast Cancer Screening Guidelines Whats Changed in 2025 4"},{"@type":"BreadcrumbList","@id":"https:\/\/massivebio.com\/breast-cancer-screening-guidelines-whats-changed-in-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Homepage","item":"https:\/\/massivebio.com\/"},{"@type":"ListItem","position":2,"name":"Blog","item":"https:\/\/massivebio.com\/blog-en\/"},{"@type":"ListItem","position":3,"name":"Breast Cancer Screening Guidelines: What\u2019s Changed in 2025?"}]},{"@type":"WebSite","@id":"https:\/\/massivebio.com\/#website","url":"https:\/\/massivebio.com\/","name":"Cancer Analysis and Clinical Trial Matching","description":"Best Oncology Advisory Services By Cancer Treatment Care Specialists &amp; Tumor Board Experts in America","publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/massivebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/massivebio.com\/#organization","name":"Massive Bio","url":"https:\/\/massivebio.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","width":"1024","height":"1024","caption":"Massive Bio"},"image":{"@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","https:\/\/x.com\/MassiveBio","https:\/\/instagram.com\/massive_bio\/","https:\/\/tiktok.com\/@massivebio","https:\/\/youtube.com\/massivebio"],"email":"support@massivebio.com","legalName":"Massive Bio"},{"@type":"Person","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6","name":"Sinan Gul"}]}},"_links":{"self":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/36324","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/comments?post=36324"}],"version-history":[{"count":1,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/36324\/revisions"}],"predecessor-version":[{"id":36326,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/36324\/revisions\/36326"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media\/36325"}],"wp:attachment":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media?parent=36324"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/categories?post=36324"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/tags?post=36324"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}